NHS to Offer Wegovy to 1.2M for Heart Attack & Stroke Prevention
The NHS will soon offer Wegovy (semaglutide), a GLP-1 drug, to 1.2 million people with cardiovascular disease to prevent heart attacks and strokes. A major preventative health initiative.